Unique PGx breadth Inagene offers pharmacogenetic testing with one of the broadest gene/variant panels in Canada, enabling personalized medication and nutrition guidance. This presents a sales opportunity to partner with healthcare providers, pharmacies, and payers seeking comprehensive pharmacogenomics solutions.

CLIA Lab Advantage Testing is conducted in a CLIA-accredited Toronto lab with Health Canada licensing, which can reassure clinicians and institutions about reliability and regulatory compliance. Target hospitals, clinics, and regional health networks that require accredited analytics.

Cardio Test Launch Recently launched Cardiovascular Health Test positions Inagene in a high-demand niche. Leverage this for cross-sell to cardiology practices, primary care groups, and digital health platforms focusing on cardiovascular risk and medication optimization.

Growth Potential Revenue is in the low to mid single-digit millions with a small employee base, indicating potential for scalable partnerships, field sales through distributors, and channel strategies with independent pharmacies and integrated care networks.

Strategic Partnerships Past collaborations with Granville Biomedical and industry groups (pharmacy professionals) show openness to ecosystem partnerships. Use this to propose co-branded education programs, training series, and joint go-to-market initiatives to expand adoption.